A new trading day began on Friday, with Soleno Therapeutics Inc (NASDAQ: SLNO) stock price down -3.17% from the previous day of trading, before settling in for the closing price of $44.52. SLNO’s price has ranged from $36.61 to $60.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -78.95%. With a float of $32.15 million, this company’s outstanding shares have now reached $41.04 million.
The firm has a total of 42 workers. Let’s measure their productivity. In terms of profitability, gross margin is 57.25%, operating margin of -3995.07%, and the pretax margin is -3806.27%.
Soleno Therapeutics Inc (SLNO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Soleno Therapeutics Inc is 25.52%, while institutional ownership is 78.44%. The most recent insider transaction that took place on Jan 02 ’25, was worth 114,431. In this transaction an insider of this company sold 2,520 shares at a rate of $45.41, taking the stock ownership to the 78,945 shares. Before that another transaction happened on Jan 03 ’25, when Company’s insider sold 2,340 for $46.18, making the entire transaction worth $108,053. This insider now owns 76,605 shares in total.
Soleno Therapeutics Inc (SLNO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -78.95% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Here are Soleno Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.31, a number that is poised to hit -1.06 in the next quarter and is forecasted to reach -2.60 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Analysing the last 5-days average volume posted by the [Soleno Therapeutics Inc, SLNO], we can find that recorded value of 0.48 million was lower than the volume posted last year of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 22.98%. Additionally, its Average True Range was 2.13.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 3.31%, which indicates a significant decrease from 13.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.16% in the past 14 days, which was lower than the 48.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.81, while its 200-day Moving Average is $47.25. Now, the first resistance to watch is $43.96. This is followed by the second major resistance level at $44.81. The third major resistance level sits at $45.54. If the price goes on to break the first support level at $42.38, it is likely to go to the next support level at $41.65. Should the price break the second support level, the third support level stands at $40.80.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
With a market capitalization of 1.86 billion, the company has a total of 43,117K Shares Outstanding. Currently, annual sales are 0 K while annual income is -38,990 K. The company’s previous quarter sales were 0 K while its latest quarter income was -76,620 K.
